Nasopharyngeal flora in children with acute otitis media before and after implementation of 7 valent pneumococcal conjugate vaccine in France

Robert Cohen, Edouard Bingen, Corinne Levy, Franck Thollot, Michel Boucherat, Véronique Derkx, Emmanuelle Varon, Robert Cohen, Edouard Bingen, Corinne Levy, Franck Thollot, Michel Boucherat, Véronique Derkx, Emmanuelle Varon

Abstract

Background: Several studies have investigated the impact of 7-valent pneumococcal conjugate vaccine (PCV7) on pneumococcal (Sp) and staphylococcal (Sa) nasopharyngeal (NP) carriage. Few have investigated the impact on Haemophilus influenzae (Hi) and Moraxella catarrhalis (Mc) carriage. We aimed to compare the NP carriage rates in young children with acute otitis media (AOM) before and after PCV7 implementation in France.

Methods: Prior to PCV7 implementation, we performed 4 successive randomized trials with NP samples. These studies compared several antibiotic regimens for treating AOM in young children (6 to 30 months). After PCV7 implementation, to assess the impact of the vaccination program on NP flora, young children with AOM were enrolled in a prospective surveillance study. In each study, we obtained an NP sample to analyze the carriage rates of Sp, Hi, Mc and Sa and the factors influencing the carriage. Standardized history and physical examination findings were recorded; the methods used for NP swabs (sampling and cultures) were the same in all studies.

Results: We enrolled 4,405 children (mean age 13.9 months, median 12.8). Among the 2,598 children enrolled after PCV7 implementation, 98.3% were vaccinated with PCV7. In comparing the pre- and post-PCV7 periods, we found a slight but non-significant decrease in carriage rates of pneumococcus (AOR = 0.85 [0.69;1.05]), H. influenzae (AOR = 0.89 [0.73;1.09]) and S. aureus (AOR = 0.92 [0.70;1.19]). By contrast, the carriage rate of M. catarrhalis increased slightly but not significantly between the 2 periods (AOR = 1.08 [0.95;1.2]). Among Sp carriers, the proportion of PCV7 vaccine types decreased from 66.6% to 10.7% (P < 0.001), penicillin intermediate-resistant strains increased from 30.3% to 43.4% (P < 0.001), and penicillin-resistant strains decreased greatly from 22.8% to 3.8% (P < 0.001). The proportion of Hi ß-lactamase-producing strains decreased from 38.6% to 17.1% (P < 0.001).

Conclusion: The carriage rates of otopathogen species (Sp, Hi, Mc) and Sa did not significantly change in children with AOM after PCV7 implementation in France. However, we observed significant changes in carriage rates of PCV7 vaccine serotypes and penicillin non-susceptible Sp.

Figures

Figure 1
Figure 1
Distribution of serotypes before and after 7-valent pneumococcal conjugate vaccine (PCV7) implementation.

References

    1. Faden H, Stanievich J, Brodsky L, Bernstein J, Ogra PL. Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J. 1990;9(9):623–626.
    1. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL. The role of nasal carriage in Staphylococcus aureu infections. Lancet Infect Dis. 2005;5(12):751–762. doi: 10.1016/S1473-3099(05)70295-4.
    1. Cohen R, Levy C, Hentgen V, Boucherat M, De La-Rocque F, D'Athis P, Bingen E. Relationship between clinical signs and symptoms and nasopharyngeal flora in acute otitis media. Clin Microbiol Infect. 2006;12(7):679–682. doi: 10.1111/j.1469-0691.2006.01483.x.
    1. Faden H, Duffy L, Wasielewski R, Wolf J, Krystofik D, Tung Y. Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics J Infect Dis. 1997;175(6):1440–1445.
    1. Leibovitz E, Jacobs MR, Dagan R. Haemophilus influenza: a significant pathogen in acute otitis media. Pediatr Infect Dis J. 2004;23(12):1142–1152.
    1. Howie VM, Ploussard JH, Lester RL Jr. Otitis media: a clinical and bacteriological correlation. Pediatrics. 1970;45(1):29–35.
    1. Broides A, Dagan R, Greenberg D, Givon-Lavi N, Leibovitz E. Acute otitis media caused by Moraxella catarrhalis: epidemiologic and clinical characteristics. Clin Infect Dis. 2009;49(11):1641–1647. doi: 10.1086/647933.
    1. Anonymous. French vaccinal calendar. Bull Epidemiol Hebd. 2006;29-30:212–224.
    1. Gaudelus J, Cohen R. Evolution of PCV7 coverage in 2006 to 2010: analysis of health records. Medecine et Enfance. 2011;31(4):187–190.
    1. Klugman KP. Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance. Lancet Infect Dis. 2001;1(2):85–91. doi: 10.1016/S1473-3099(01)00063-9.
    1. Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K, Pelton SI, Lipsitch M, Hanage WP, Lee GM, Finkelstein JA. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics. 2009;124(1):e1–e11. doi: 10.1542/peds.2008-3099.
    1. Cohen R, Levy C, Bonnet E, Grondin S, Desvignes V, Lecuyer A, Fritzell B, Varon E. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine. 2010;28(37):6114–6121. doi: 10.1016/j.vaccine.2009.05.037.
    1. Paradise JL. On classifying otitis media as suppurative or nonsuppurative, with a suggested clinical schema. J Pediatr. 1987;111(6 Pt 1):948–951.
    1. Cohen R, Levy C, Boucherat M, Langue J, de La Rocque F. A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children. J Pediatr. 1998;133(5):634–639. doi: 10.1016/S0022-3476(98)70103-9.
    1. Cohen R, Levy C, Boucherat M, Langue J, Autret E, Gehanno P, de La Rocque F. Five vs. ten days of antibiotic therapy for acute otitis media in young children. Pediatr Infect Dis J. 2000;19(5):458–463. doi: 10.1097/00006454-200005000-00013.
    1. Cohen R, De La-Rocque F, Boucherat M. et al.A Randomized trial cefpodoximeproxetil 5 days vs amoxicillin-clavulanate 8 days in children with acute otitis media. Med Mal Infect. 1997;27:596–602. doi: 10.1016/S0399-077X(97)80091-1.
    1. Cohen R, Levy C, Thollot F, de La Rocque F, Koskas M, Bonnet E, Fritzell B, Varon E. Pneumococcal conjugate vaccine does not influence Staphylococcus aureu carriage in young children with acute otitis media. Clin Infect Dis. 2007;45(12):1583–1587. doi: 10.1086/523734.
    1. Cohen R, Levy C, Bingen E, Koskas M, Nave I, Varon E. Impact of 13-Valent Pneumococcal Conjugate Vaccine On Pneumococcal Nasopharyngeal Carriage in Children with Acute Otitis Media. Pediatr Infect Dis J. 2012. in press .
    1. Cohen R, Levy C, Bonnet E, Thollot F, Boucherat M, Fritzell B, Derkx V, Bingen E, Varon E. Risk factors for serotype 19A carriage after introduction of 7-valent pneumococcal vaccination. BMC Infect Dis. 2011;11:95. doi: 10.1186/1471-2334-11-95.
    1. Cohen R, Levy C, de La Rocque F, Gelbert N, Wollner A, Fritzell B, Bonnet E, Tetelboum R, Varon E. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Pediatr Infect Dis J. 2006;25(11):1001–1007. doi: 10.1097/01.inf.0000243163.85163.a8.
    1. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 18th informational supplement. CLSI document M100-S18. Wayne, Pa. 2008.
    1. Madhi SA, Adrian P, Kuwanda L, Cutland C, Albrich WC, Klugman KP. Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae-and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization-in HIV-Infected and HIV-uninfected children. J Infect Dis. 2007;196(11):1662–1666. doi: 10.1086/522164.
    1. van Gils EJ, Veenhoven RH, Rodenburg GD, Hak E, Sanders EA. Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage with Haemophilus influenzae and Moraxella catarrhalis in a randomized controlled trial. Vaccine. 2011;29(44):7595–7598. doi: 10.1016/j.vaccine.2011.08.049.
    1. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J. 2004;23(9):824–828. doi: 10.1097/01.inf.0000136871.51792.19.
    1. Levy C, Thollot F, Corrard F, Lecuyer A, Martin P, Boucherat M, Koskas M, Romain O, Goldrey M, Hausdorff WP. et al.[Acute otitis media in ambulatory practice: Epidemiological and clinical characteristics after 7 valent pneumococcal conjugate vaccine (PCV7) implementation.] Arch Pediatr. 2011;18(6):712–718. doi: 10.1016/j.arcped.2011.03.010.
    1. Sabuncu E, David J, Bernede-Bauduin C, Pepin S, Leroy M, Boelle PY, Watier L, Guillemot D. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med. 2009;6(6):e1000084. doi: 10.1371/journal.pmed.1000084.
    1. Dabernat H, Seguy M, Faucon G, Delmas C. Epidemiology of Haemophilus influenza strains collected in 2004 in France and in vitro assessment of their susceptibility to antibiotics. Med Mal Infect. 2007;37(6):320–324. doi: 10.1016/j.medmal.2006.10.014.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera